Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

So What's Up With AMD And Nvidia Shares Falling Today?

NVIDIA Corporation (NASDAQ: NVDA) shares are trading lower after Baird downgraded the stock from Outperform to Neutral and lowered its price target from $360 to $225.

Benzinga

SVB Leerink Maintains Market Perform Rating for Rubius Therapeutics, Lowers Price Target To $3

SVB Leerink has decided to maintain its Market Perform rating of Rubius Therapeutics (NASDAQ:RUBY) and lower its price target from $5.00 to $3.00. Shares of Rubius Therapeutics are trading down 24.14% over the last 24 hours, at $2.42 per share.

Benzinga

B. Riley Securities Maintains Buy Rating for Silicon Motion Technology, Lowers Price Target To $106

B. Riley Securities has decided to maintain its Buy rating of Silicon Motion Technology (NASDAQ:SIMO) and lower its price target from $135.00 to $106.00. Shares of Silicon Motion Technology are trading down 1.6% over the last 24 hours, at $70.84 per share.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Guggenheim Maintains Buy Rating for Rubius Therapeutics, Lowers Price Target To $5

Guggenheim has decided to maintain its Buy rating of Rubius Therapeutics (NASDAQ:RUBY) and lower its price target from $25.00 to $5.00. Shares of Rubius Therapeutics are trading down 24.14% over the last 24 hours, at $2.42 per share.

Benzinga

HC Wainwright & Co. Maintains Buy Rating for Aadi Bioscience, Lowers Price Target To $48

HC Wainwright & Co. has decided to maintain its Buy rating of Aadi Bioscience (NASDAQ:AADI) and lower its price target from $49.00 to $48.00. Shares of Aadi Bioscience are trading down 4.87% over the last 24 hours, at $16.62 per share.

Benzinga

Oppenheimer Maintains Outperform Rating for BioCryst Pharmaceuticals, Lowers Price Target To $16

Oppenheimer has decided to maintain its Outperform rating of BioCryst Pharmaceuticals (NASDAQ:BCRX) and lower its price target from $20.00 to $16.00. Shares of BioCryst Pharmaceuticals are trading down 1.62% over the last 24 hours, at $10.94 per share.

Benzinga

Credit Suisse Maintains Outperform Rating for Ross Stores, Raises Price Target To $125

Credit Suisse has decided to maintain its Outperform rating of Ross Stores (NASDAQ:ROST) and raise its price target from $118.00 to $125.00. Shares of Ross Stores are trading up 3.27% over the last 24 hours, at $100.01 per share.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Elon Musk To Pump NFTs Next? NFT Creator Beeple Acknowledged By Tesla CEO

Elon Musk — tech tycoon and CEO of electric vehicle manufacturer Tesla Inc. (NASDAQ: TSLA) — clearly started paying attention to the non-fungible token (NFT) industry, as shown by his Twitter Inc. (NYSE:

Benzinga

Kyowa Kirin, Ardelyx Amend Tenapanor Pact In Cardiorenal Disorders

Ardelyx Inc (NASDAQ: ARDX) has

Benzinga

So What's Up With Microsoft Shares Falling Today?

Shares of companies in the broader technology sector, including Microsoft Corporation (NASDAQ: MSFT), are trading lower amid a rise in US Treasury yields.

Benzinga

Analyst Ratings For Goodyear Tire & Rubber

Within the last quarter, Goodyear Tire & Rubber (NASDAQ:GT) has observed the following analyst ratings:

Benzinga

Broadcom Whale Trades Spotted

Someone with a lot of money to spend has taken a bullish stance on Broadcom (NASDAQ:AVGO). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Analyst Ratings For Roku

Analysts have provided the following ratings for Roku (NASDAQ:ROKU) within the last quarter:

Benzinga

Analyzing Walgreens Boots Alliance Inc's Short Interest

Walgreens Boots Alliance Inc's (NASDAQ:WBA) short percent of float has fallen 14.69% since its last report. The company recently reported that it has 17.45 million shares sold short, which is 2.44% of all regular shares that are available for trading.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

What 4 Analyst Ratings Have To Say About IAC/InterActive

Analysts have provided the following ratings for IAC/InterActive (NASDAQ:IAC) within the last quarter:

Benzinga

Analyst Ratings For Match Group

Within the last quarter, Match Group (NASDAQ:MTCH) has observed the following analyst ratings:

Benzinga

WillScot Mobile Mini Acquires Storstac For Undisclosed Sum

Willscot Mobile Mini Holdings Corp (NASDAQ:WSC) closed the acquisition of Canadian storage services provider Storstac Inc. Deal terms were not disclosed. This acquisition adds over 1,100 storage units to WSC's existing markets in the greater Toronto area. The company funded the transaction with cash on hand and borrowings under its revolving credit agreement.…

Benzinga

Insurance Stocks Moving In Monday's Intraday Session

According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

BZ Chart of the Day: QQQ Gaps Lower

It looks like the selloff in the technology sector will continue. The Invesco QQQ Trust ETF (NASDAQ: QQQ) is gapping lower. The bears seem to be firmly in control.

Benzinga

5 Cannabis Stocks Wall Street Analysts Rate Buy: No, Tilray Is Not Among Them

The cannabis industry blossomed during the pandemic, some say unexpect

Benzinga

Was WWE's WrestleMania 38 Bigger Than Super Bowl LVI? Here's What Social Media Data Says

When it comes to social media popularity, the spectacle of Brock Lesnar and Roman Reigns pummeling each other was more popular than the matchup between the Los Angeles Rams and the Cincinnati Bengals.

Benzinga

Cellectis Reveals Preclinical Data On First Allogeneic Dual CAR T-Cell Product In Non-Hodgkin Lymphoma

Cellectis SA (NASDAQ:CLLS) released preclinical data on its product candidate UCART20x22 at the American Association for Cancer Research (AACR) Annual Meeting. The Company said that the data showed preclinical proof of concept with the potential to overcome common mechanisms of resistance to CAR T-cell therapies in relapsed or refractory Non-Hodgkin Lymphoma (r/r NHL),…

Benzinga

Merger Arbitrage Mondays - WindAcre Doubles Its Stake In Nielsen Holdings (NLSN) And Other Deals

Merger activity decreased last week with three new deals announced and six deals completed. Tivity Health (NASDAQ: TVTY)

Benzinga

If You Invested $1,000 In Microsoft Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now

Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than others since the pandemic bottom.

Benzinga

Where GoodRx Holdings Stands With Analysts

Over the past 3 months, 13 analysts have published their opinion on GoodRx Holdings (NASDAQ:GDRX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

1 … 766 767 768 769

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.